Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stock

Showing results (231-240 of 546) with videos related to

Pageof 55
Sort By:
BJU International|June 5, 2009
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapyRichard G Stock, Jamie A Cesaretti, Simon J Hall, et al.
Brachytherapy|February 8, 2007
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFSTimothy M Zagar, Richard G Stock, Jamie A Cesaretti, et al.
Brachytherapy|January 13, 2019
Long-term oncological and functional outcomes support use of low-dose-rate brachytherapy with or without external beam radiation in young men (≤60 years) with localized prostate cancerJared S Winoker, Olamide O Omidele, Richard G Stock, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy resultsRichard G Stock, Nelson N Stone, Jamie A Cesaretti, et al.
The Journal of Clinical Investigation|June 18, 2021
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipientsPeter G Stock, Timothy J Henrich, Dorry L Segev, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|July 1, 1986
[Diagnosis and treatment of cardiac rhabdomyomas]A Gillor, G Stock, D Schuster, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2016
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosisOren K Fix, Peter G Stock, Brian K Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel diseaseChristopher A Peters, Jamie A Cesaretti, Nelson N Stone, et al.
Psychiatry (Edgmont (Pa. : Township))|September 3, 2009
Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety DisorderVladimir Coric, Elyse G Stock, Joseph Pultz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapyRichard G Stock, Thomas J Klein, Jamie A Cesaretti, et al.
Pageof 55

Showing results (231-240 of 546) with videos related to

Sort By:
Pageof 55
BJU International|June 5, 2009
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapyRichard G Stock, Jamie A Cesaretti, Simon J Hall, et al.
Brachytherapy|February 8, 2007
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFSTimothy M Zagar, Richard G Stock, Jamie A Cesaretti, et al.
Brachytherapy|January 13, 2019
Long-term oncological and functional outcomes support use of low-dose-rate brachytherapy with or without external beam radiation in young men (≤60 years) with localized prostate cancerJared S Winoker, Olamide O Omidele, Richard G Stock, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy resultsRichard G Stock, Nelson N Stone, Jamie A Cesaretti, et al.
The Journal of Clinical Investigation|June 18, 2021
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipientsPeter G Stock, Timothy J Henrich, Dorry L Segev, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|July 1, 1986
[Diagnosis and treatment of cardiac rhabdomyomas]A Gillor, G Stock, D Schuster, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2016
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosisOren K Fix, Peter G Stock, Brian K Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel diseaseChristopher A Peters, Jamie A Cesaretti, Nelson N Stone, et al.
Psychiatry (Edgmont (Pa. : Township))|September 3, 2009
Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety DisorderVladimir Coric, Elyse G Stock, Joseph Pultz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapyRichard G Stock, Thomas J Klein, Jamie A Cesaretti, et al.
Pageof 55